| Recruiting | A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Brea NCT07174336 | Eli Lilly and Company | Phase 3 |
| Recruiting | A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract NCT07218380 | Eli Lilly and Company | Phase 3 |
| Recruiting | A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) NCT07213804 | Eli Lilly and Company | Phase 3 |
| Not Yet Recruiting | Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an A NCT07151586 | UNICANCER | Phase 2 |
| Recruiting | Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC NCT06912087 | University of Chicago | Phase 1 |
| Recruiting | A Study of LY4257496 in Participants With Cancer (OMNIRAY) NCT07114601 | Eli Lilly and Company | Phase 1 |
| Recruiting | A Study of LY4175408 in Participants With Advanced Cancer NCT07046923 | Eli Lilly and Company | Phase 1 |
| Withdrawn | A Study of Pembrolizumab in Combination With Investigational Agents in Pediatric and Young Adult Participants NCT06395090 | Merck Sharp & Dohme LLC | Phase 1 / Phase 2 |
| Active Not Recruiting | Virtual Reality for Advanced Cancer Pain NCT06534580 | University College, London | — |
| Completed | Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by NCT06538623 | Ruijin Hospital | Phase 2 |
| Not Yet Recruiting | Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer NCT06539559 | Wang Jiayu | Phase 2 |
| Active Not Recruiting | A Study of MK-6837 as a Monotherapy and Combination Therapy in Participants With Advanced/Metastatic Solid Tum NCT06460961 | Merck Sharp & Dohme LLC | Phase 1 |
| Recruiting | Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma NCT06532539 | Shandong Cancer Hospital and Institute | Phase 2 |
| Recruiting | A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With A NCT06119581 | Eli Lilly and Company | Phase 3 |
| Recruiting | PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Cl NCT05573893 | AstraZeneca | — |
| Withdrawn | Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study NCT06057636 | The University of Tennessee, Knoxville | N/A |
| Unknown | Application of a New Type of Whole Blood Coagulation Time Measurement in Evaluating the Hypercoagulable State NCT05939960 | Tianjin Medical University General Hospital | — |
| Recruiting | Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. NCT06046131 | Centre Hospitalier Universitaire de la Guadeloupe | N/A |
| Completed | Proof-of-concept Study of Blood Markers of Tumor Dissemination in Patients With Versus Without Intestinal Poly NCT05648240 | Centre Hospitalier Universitaire de Nīmes | — |
| Withdrawn | A Study of CodaLytic, an Intratumoral Oncolytic Virus, in Patients With Breast Cancer NCT05600582 | Codagenix, Inc | Phase 1 |
| Recruiting | FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3 NCT05614739 | Eli Lilly and Company | Phase 1 |
| Withdrawn | Stereotactic Body Radiotherapy Followed by Surgical Stabilization in Spinal Metastases NCT05060653 | UMC Utrecht | N/A |
| Active Not Recruiting | CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma NCT05440786 | Eli Lilly and Company | Phase 2 |
| Unknown | Clinical Application of Super-resolution Ultrasound(SR-US) Imaging in Solid Tumors NCT06018142 | Chinese PLA General Hospital | — |
| Active Not Recruiting | A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts NCT05288166 | Eli Lilly and Company | Phase 3 |
| Active Not Recruiting | Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Can NCT05169567 | Eli Lilly and Company | Phase 3 |
| Active Not Recruiting | Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in T NCT05103358 | Aadi Bioscience, Inc. | Phase 2 |
| Unknown | Overcome, a Program of Therapeutic Exercise and Functional Recovery to Improve the Functional Capacity of Wome NCT05244382 | Universidad de Granada | N/A |
| Terminated | Mirtazapine in Cancer-related Poly-symptomatology NCT04763135 | Hospices Civils de Lyon | Phase 3 |
| Recruiting | EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers NCT05176665 | Shanghai EpimAb Biotherapeutics Co., Ltd. | Phase 1 / Phase 2 |
| Active Not Recruiting | A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Part NCT04975308 | Eli Lilly and Company | Phase 3 |
| Recruiting | Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases NCT05023772 | Henry Ford Health System | N/A |
| Unknown | Dose Efficiency of Modern CT Scanners in Oncologic Scans NCT04989192 | University Hospital Augsburg | N/A |
| Unknown | LIVACOR Trial: Minimally Invasive LIVer And Simultaneous COlorectal Resection NCT05138094 | Fondazione Poliambulanza Istituto Ospedaliero | N/A |
| Completed | Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial NCT04283994 | University of Washington | N/A |
| Active Not Recruiting | Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Canc NCT04886804 | Boehringer Ingelheim | Phase 1 |
| Completed | Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer Patients NCT04790968 | Norwegian University of Science and Technology | N/A |
| Completed | A Study of Abemaciclib in Indian Women With Advanced Breast Cancer NCT04707196 | Eli Lilly and Company | Phase 4 |
| Unknown | Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Un NCT05322486 | State Scientific Centre of Coloproctology, Russian Federation | — |
| Terminated | A Study of Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metas NCT04521621 | Merck Sharp & Dohme LLC | Phase 1 / Phase 2 |
| Terminated | Study of PF-07265807 in Participants With Metastatic Solid Tumors. NCT04458259 | Pfizer | Phase 1 |
| Completed | Do Patients Want to Engage in Discussions Dedicated to Anticipating (DDA) Their Preferences of Care in the Eve NCT04308356 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Microwave Ablation of Primary and Secondary Lung Malignancies NCT04369872 | University of Calgary | Phase 1 / Phase 2 |
| Completed | Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) NCT04281784 | University of Washington | N/A |
| Active Not Recruiting | Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases NCT04307914 | UMC Utrecht | N/A |
| Completed | A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Adva NCT04200963 | Ikena Oncology | Phase 1 |
| Terminated | SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Meta NCT03694015 | British Columbia Cancer Agency | N/A |
| Terminated | A Study of Intratumoral/Intralesional Administration of V938 in Combination With Pembrolizumab (MK-3475) in Pa NCT04135352 | Merck Sharp & Dohme LLC | Phase 1 |
| Terminated | Cryoablation of Bone Metastases From Endocrine Tumors NCT03986593 | Instituto do Cancer do Estado de São Paulo | N/A |
| Completed | CIRSE Emprint Microwave Ablation Registry NCT03775980 | Cardiovascular and Interventional Radiological Society of Europe | — |
| Completed | Treatment of Colorectal Liver Metastases With Immunotherapy and Bevacizumab NCT03698461 | Asan Medical Center | Phase 2 |
| Completed | A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Lo NCT03785925 | Nektar Therapeutics | Phase 2 |
| Completed | Facilitating Communication Study NCT03721952 | University of Washington | N/A |
| Completed | Feasibility of Combined Focused Ultrasound and Radiotherapy Treatment in Patients With Painful Bone Metastasis NCT04310410 | UMC Utrecht | Phase 1 / Phase 2 |
| Completed | A Trial to Improve Quality of Life With Stereotactic Body Radiotherapy for Patients With Painful Bone Metastas NCT03831243 | Cancer Research Antwerp | N/A |
| Completed | Platform Trial Evaluating Safety and Efficacy of Ezabenlimab Anti- PD-1 Based Combination Therapies in PD-(L)1 NCT03697304 | Boehringer Ingelheim | Phase 2 |
| Active Not Recruiting | 9-ING-41 in Patients With Advanced Cancers NCT03678883 | Actuate Therapeutics Inc. | Phase 2 |
| Unknown | Combination of Proton Therapy With Immunotherapy in Multiple Metastases Cancer NCT03765190 | Peking University First Hospital | Phase 1 / Phase 2 |
| Unknown | A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors NCT03797391 | Shanghai EpimAb Biotherapeutics Co., Ltd. | Phase 1 / Phase 2 |
| Unknown | DEBOXA for Inoperable NET Liver Metastases NCT03881306 | Xiangya Hospital of Central South University | Phase 1 / Phase 2 |
| Unknown | Local Treatment With RP for Newly-diagnosed mPCa NCT02138721 | University Hospital, Ghent | N/A |
| Completed | Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Sol NCT03510104 | Meryx, Inc. | Phase 1 |
| Active Not Recruiting | Hepatic Resection for Metastatic Pancreatic Cancer NCT02892305 | Duke University | — |
| Completed | CIRSE Registry for LifePearl Microspheres NCT03086096 | Cardiovascular and Interventional Radiological Society of Europe | — |
| Completed | A Study of ASN007 in Patients With Advanced Solid Tumors NCT03415126 | Asana BioSciences | Phase 1 |
| Completed | Study of DS-8201a for Participants With Advanced Solid Malignant Tumors NCT03383692 | Daiichi Sankyo Co., Ltd. | Phase 1 |
| Recruiting | Bone Metastases Database of Patients Treated Surgically for Impending or Pathologic Fracture of Long Bones NCT03416959 | Istituto Ortopedico Rizzoli | — |
| Completed | FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, NCT03142516 | Grupo Espanol Multidisciplinario del Cancer Digestivo | Phase 2 |
| Withdrawn | Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension NCT03029416 | Ronald McGarry | Phase 2 |
| Terminated | A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable NCT03166631 | Boehringer Ingelheim | Phase 1 |
| Unknown | A Study to See Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver Safely NCT03175146 | AHS Cancer Control Alberta | N/A |
| Completed | A Patient Navigation Program to Increase Access to Early Supportive Care in Patients With Stage IV Solid Tumor NCT03293849 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | N/A |
| Unknown | Standardization of Multi-modal Tumor Ablation Therapy System NCT03223142 | Shanghai Zhongshan Hospital | N/A |
| Completed | A Study of AK-01 (LY3295668) in Solid Tumors NCT03092934 | Eli Lilly and Company | Phase 1 / Phase 2 |
| Unknown | Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions NCT03129412 | Zhejiang Cancer Hospital | Phase 2 |
| Unknown | Metastatic Spinal Cord Compression (MSCC): Treatment Timing and Survival Rate NCT02934594 | National Taiwan University Hospital | — |
| Completed | A Trial to Strengthen Existential Resiliency Among Women With Metastatic Breast Cancer NCT02707510 | Cedars-Sinai Medical Center | N/A |
| Completed | A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer NCT02677116 | Eli Lilly and Company | Phase 1 |
| Terminated | Resection Versus Microwave Ablation for Resectable Colorectal Cancer Liver Metastases NCT02866344 | Wake Forest University Health Sciences | N/A |
| Withdrawn | Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metast NCT02839694 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Whole Brain Radiotherapy (WBRT) Versus Stereotactic Radiosurgery (SRS) for 4 Upto 10 Brain Metastases NCT02353000 | Maastricht Radiation Oncology | N/A |
| Terminated | Essential Oils on Anxiety of Patients Suffering From Cancer NCT02835352 | Center Eugene Marquis | N/A |
| Completed | Safety Study of Adoptive Transfer of Autologous IKDC-like Cells NCT02661685 | National Defense Medical Center, Taiwan | Phase 1 |
| Completed | Whole Brain Radiation Using IMRT for Patients With Brain Metastases NCT02753790 | New Mexico Cancer Research Alliance | N/A |
| Completed | A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Bo NCT02688088 | Eli Lilly and Company | Phase 1 |
| Completed | Multicenter Study of Cryoablation for Palliation of Painful Bone Metastases NCT02511678 | Boston Scientific Corporation | N/A |
| Unknown | Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B) NCT02953717 | Elisabeth-TweeSteden Ziekenhuis | N/A |
| Completed | Microwave Ablation Versus Resection for Resectable Colorectal Liver Metastases NCT02642185 | Karolinska Institutet | — |
| Unknown | Mediastinal Lymph Node Dissection in Conjunction With Pulmonary Metastasectomy From Colorectal Cancer NCT03113318 | Rigshospitalet, Denmark | N/A |
| Terminated | Super-selective Intra-arterial Cerebral Infusion of Trastuzumab for the Treatment of Cerebral Metastases of HE NCT02571530 | Northwell Health | Phase 1 |
| Unknown | Negative Pressure Wound Therapy in Groin Dissection NCT02408835 | South Eastern Health and Social Care Trust | N/A |
| Completed | A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC) NCT02411591 | Eli Lilly and Company | Phase 1 |
| Completed | Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients NCT02583828 | Capital Medical University | N/A |
| Completed | Stereotactic Body Radiotherapy Followed by Surgical Stabilization for Patients With Unstable Spinal Metastases NCT02622841 | UMC Utrecht | Phase 1 / Phase 2 |
| Completed | Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer Surgery NCT02801409 | Peking University First Hospital | N/A |
| Completed | Colorectal Cancer With Liver-limited Synchronous Metastases: an Inception Cohort Study of Standardised Care Pa NCT02456285 | Manchester University NHS Foundation Trust | — |
| Completed | A Study of LY3022855 In Participants With Breast or Prostate Cancer NCT02265536 | Eli Lilly and Company | Phase 1 |
| Completed | Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma NCT02406170 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 1 / Phase 2 |
| Unknown | Clinical Trial Comparing Carnoy's and GEWF Solutions for Lymph Node Clearing Technique in Colorectal Cancer NCT02495532 | Hospital Moinhos de Vento | N/A |
| Terminated | Safety Study of SEA-CD40 in Cancer Patients NCT02376699 | Seagen Inc. | Phase 1 |
| Terminated | Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors NCT02313012 | Celgene | Phase 1 |
| Unknown | Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer NCT02352571 | Green Cross Corporation | Phase 1 |
| Unknown | Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid Tumors NCT02342158 | Institut Paoli-Calmettes | N/A |
| Unknown | Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization NCT02208804 | UMC Utrecht | Phase 2 / Phase 3 |
| Unknown | A Longitudinal Study of Colorectal Cancer Patients With Metastatic Disease in Middle-Norway NCT02395224 | Norwegian University of Science and Technology | — |
| Completed | Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients NCT02374411 | Edward Hospital | — |
| Completed | A Study of LY3164530 in Participants With Cancer NCT02221882 | Eli Lilly and Company | Phase 1 |
| Unknown | Dendritic Killer Cell-based Immunotherapy for Solid Tumors NCT02882659 | FullHope Biomedical Co., Ltd. | Phase 1 |
| Completed | Volumetric Intensity Modulated Arc Therapy vs. Conventional Radiotherapy for Cancer Pain NCT03374592 | Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
| Terminated | Stereotactic Radiosurgery in Metastatic Spinal Cord Compression NCT02167633 | Rigshospitalet, Denmark | N/A |
| Completed | A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer NCT02124148 | Eli Lilly and Company | Phase 1 |
| Completed | Study of Cryoablation for Metastatic Lung Tumors NCT01957787 | Boston Scientific Corporation | N/A |
| Completed | A Study of LY2835219 in Participants With Cancer NCT02117648 | Eli Lilly and Company | Phase 1 |
| Completed | HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry NCT02082886 | Edward-Elmhurst Health System | — |
| Completed | A Study of LY2835219 in Japanese Participants With Advanced Cancer NCT02014129 | Eli Lilly and Company | Phase 1 |
| Completed | A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC NCT01996306 | Epidemiological and Clinical Research Information Network | Phase 3 |
| Completed | The Palliative Radiotherapy And Inflammation Study - PRAIS NCT02107664 | Norwegian University of Science and Technology | — |
| Terminated | A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Bo NCT02014116 | Eli Lilly and Company | Phase 1 |
| Unknown | Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC NCT01917279 | Binghe Xu | Phase 3 |
| Completed | Improving Communication About Serious Illness NCT01933789 | University of Washington | N/A |
| Terminated | Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain NCT01846429 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 |
| Unknown | Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study NCT01960829 | Peking University Cancer Hospital & Institute | Phase 2 |
| Completed | A Study of LY2940680 in Japanese Participants With Advanced Cancers NCT01919398 | Eli Lilly and Company | Phase 1 |
| Withdrawn | Safety and Efficacy of Cryoablation Combined With Radiation Therapy for the Palliation of Painful Bone Metasta NCT01461252 | Boston Scientific Corporation | Phase 1 |
| Completed | FoundationOne™ Test Registry Study NCT01851213 | Foundation Medicine | — |
| Completed | Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent o NCT01737450 | Centre Leon Berard | Phase 2 |
| Completed | Biliary or Digestive Protection by Room Air Interposition for Thermal Ablation of Central Hepatic Tumors NCT05495529 | Centre Hospitalier Universitaire de Nice | — |
| Unknown | Proteome-based Immunotherapy of Lung Cancer Brain Metastases NCT01782287 | NeuroVita Clinic | Phase 2 / Phase 3 |
| Unknown | Proteome-based Immunotherapy of Brain Metastases From Breast Cancer NCT01782274 | NeuroVita Clinic | Phase 2 / Phase 3 |
| Completed | CCR5-blockade in Metastatic Colorectal Cancer NCT01736813 | National Center for Tumor Diseases, Heidelberg | — |
| Completed | Study of LY2157299 in Japanese Participants With Cancer NCT01722825 | Eli Lilly and Company | Phase 1 |
| Completed | Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP) NCT01711684 | Rockefeller University | Phase 1 |
| Completed | A Study of LY3039478 in Participants With Advanced Cancer NCT01695005 | Eli Lilly and Company | Phase 1 |
| Unknown | Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Cancer NCT02228356 | Universitair Ziekenhuis Brussel | — |
| Unknown | Risk Adapted SABR(SABR) in Stage I NSCLC And Lung Metastases NCT01823003 | Institut Català d'Oncologia | Phase 2 |
| Completed | New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited Metastases NCT01307878 | Fudan University | Phase 3 |
| Terminated | Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer NCT01499160 | University of Maryland, Baltimore | Phase 2 |
| Terminated | A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test NCT01649453 | Cedar Associates LLC | — |
| Completed | Fractionated Radiosurgery for Painful Spinal Metastases NCT01594892 | Wuerzburg University Hospital | N/A |
| Unknown | A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC NCT03303495 | Sun Yat-sen University | Phase 3 |
| Completed | Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases NCT01461265 | Boston Scientific Corporation | Phase 1 |
| Completed | Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor NCT01441596 | Boehringer Ingelheim | Phase 2 |
| Terminated | ECI301 and Radiation for Advanced or Metastatic Cancer NCT01441115 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patien NCT01395056 | Peking University Cancer Hospital & Institute | — |
| Completed | A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer NCT01373164 | Eli Lilly and Company | Phase 1 / Phase 2 |
| Terminated | Biomarker Development for Response Prediction by DNA Mutational Analysis NCT01855061 | P.O. Witteveen | — |
| Completed | Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologi NCT01353625 | Celgene | Phase 1 |
| Unknown | Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma NCT01442324 | Azienda Ospedaliera di Padova | N/A |
| Completed | Hepatic Artery Infusion Pump for NPC Liver Metastases NCT03876574 | Xiangya Hospital of Central South University | Phase 1 |
| Completed | Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion NCT01256801 | Peking University Cancer Hospital & Institute | — |
| Withdrawn | Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome NCT01178151 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 2 |
| Completed | Whole Brain Radiation Therapy With Boost to Metastatic Tumor Volume Using RapidArc NCT01218542 | Emory University | N/A |
| Completed | Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) NCT01231022 | Peking University Cancer Hospital & Institute | — |
| Completed | Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Nega NCT01232062 | Peking University Cancer Hospital & Institute | — |
| Completed | Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy NCT01198301 | Peking University Cancer Hospital & Institute | — |
| Unknown | Study to Evaluate a High Intensity Focused Ultrasound (HIFU) Procedure in Patient With Liver Metastases NCT01489787 | Centre Leon Berard | N/A |
| Terminated | GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and NCT01118975 | University of Maryland, Baltimore | Phase 1 / Phase 2 |
| Completed | A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors NCT01011972 | Mersana Therapeutics | Phase 1 |
| Unknown | Gastric Cancer Liver Metastasis Cohort of China NCT04574245 | Chinese PLA General Hospital | — |
| Terminated | Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors NCT00908024 | Bristol-Myers Squibb | Phase 1 / Phase 2 |
| Completed | Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases NCT01114958 | University of California, San Diego | Phase 1 |
| Completed | Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hep NCT00960557 | Mateon Therapeutics | Phase 1 |
| Completed | Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lun NCT00946673 | Stanford University | Phase 1 |
| Completed | Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal C NCT00921661 | Sanofi | Phase 1 |
| Completed | A Study to Test Lung Function After Radiation Therapy NCT01039649 | University of Iowa | — |
| Completed | Pilot Study to Test the Feasibility and the Efficacy of the German Language Adapted PRO-SELF© Plus Pain Contro NCT00920504 | University Hospital, Basel, Switzerland | N/A |
| Completed | A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Sprea NCT00545129 | Pfizer | Phase 2 |
| Completed | Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases NCT00928226 | Stanford University | N/A |
| Completed | Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cance NCT00851084 | Sanofi | Phase 2 |
| Completed | Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases NCT00904553 | University of Rochester | — |
| Completed | A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 We NCT00728390 | Pfizer | Phase 1 |
| Completed | A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer NCT00798135 | Indiana University | N/A |
| Active Not Recruiting | A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansin NCT00781612 | Genentech, Inc. | Phase 2 |
| Unknown | The Role of Posterior Fossa Irradiation (PFI) Plus Stereotactic Radiosurgery (SRS) for Cerebellar Metastases NCT00781209 | Tel-Aviv Sourasky Medical Center | Phase 2 |
| Completed | Health Economic Evaluation of Primovist-enhanced Liver MRI NCT00764621 | Bayer | Phase 4 |
| Unknown | Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Ca NCT01972503 | Xu jianmin | Phase 4 |
| Completed | Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Sol NCT00710268 | AstraZeneca | Phase 1 |
| Completed | Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor NCT00633269 | AstraZeneca | Phase 1 |
| Completed | A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Pat NCT00649207 | AbbVie (prior sponsor, Abbott) | Phase 1 |
| Terminated | S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regim NCT00602745 | Sanofi | Phase 3 |
| Completed | Evaluation of Pathwork Tissue of Origin (TOO) Test for Human Malignancies NCT00977639 | Stanford University | — |
| Completed | Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer NCT00582985 | Tracon Pharmaceuticals Inc. | Phase 1 |
| Unknown | Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection NCT00561522 | Fudan University | Phase 2 / Phase 3 |
| Completed | A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metast NCT00542048 | MediGene | Phase 2 |
| Completed | Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastati NCT00561470 | Sanofi | Phase 3 |
| Completed | Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer NCT00519285 | Sanofi | Phase 3 |
| Withdrawn | A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic NCT00478270 | Hoffmann-La Roche | Phase 2 |
| Completed | Phase 1, Open-label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tu NCT00492830 | Tracon Pharmaceuticals Inc. | Phase 1 |
| Unknown | Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis NCT00454519 | Wuhan University | Phase 2 |
| Completed | Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer NCT00426530 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurr NCT00440310 | Light Sciences Oncology | Phase 3 |
| Completed | Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma NCT00447330 | Duke University | Phase 2 |
| Unknown | 5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treat NCT00433927 | PD Dr. med. Volker Heinemann | Phase 3 |
| Completed | TheraSphere for the Treatment of Liver Metastases NCT00511862 | Boston Scientific Corporation | Phase 2 |
| Withdrawn | Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patie NCT00718055 | Copenhagen University Hospital at Herlev | — |
| Completed | Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases NCT00327652 | Anza Therapeutics, Inc. | Phase 1 |
| Unknown | Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer NCT01564810 | Xu jianmin | Phase 4 |
| Completed | Rapamycin With Grapefruit Juice for Advanced Malignancies NCT00375245 | University of Chicago | Phase 1 |
| Terminated | Liposomal Doxorubicin, Trastuzumab, and Docetaxel in HER2 Positive Metastatic Breast Cancer NCT00377780 | Laurence J.C. van Warmerdam | Phase 2 |
| Withdrawn | Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radi NCT00346099 | NSABP Foundation Inc | Phase 2 |
| Completed | Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer NCT00377559 | Catharina Ziekenhuis Eindhoven | Phase 2 |
| Terminated | Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patient NCT00327093 | Hospices Civils de Lyon | Phase 4 |
| Completed | BAY88-8223, Dose Finding Study in Patients With HRPC NCT00337155 | Bayer | Phase 2 |
| Completed | Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer NCT00319254 | Pfizer | Phase 2 |
| Completed | Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer NCT00317720 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients NCT00338286 | Janssen Research & Development, LLC | Phase 3 |
| Completed | A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer NCT00436423 | Korea University Anam Hospital | Phase 2 |
| Completed | Phase 2 Trial of Bevacizumab in Combination With Pemetrexed NCT00227019 | Heather Wakelee | Phase 2 |
| Completed | A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer NCT00271687 | AHS Cancer Control Alberta | Phase 2 |
| Terminated | Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metas NCT00281528 | Celgene | Phase 2 |
| Completed | A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metas NCT00280475 | Haruhiko Fukuda | Phase 3 |
| Completed | Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer NCT00323882 | Bristol-Myers Squibb | Phase 1 / Phase 2 |
| Completed | Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer. NCT00270491 | ARCAGY/ GINECO GROUP | Phase 2 |
| Completed | Safety Study of Imexon Treatment of Patients With Metastatic or Disseminated Malignancy NCT00327223 | AmpliMed Corporation | Phase 1 |
| Withdrawn | Safety Study of 2DG With Stereotactic Radiosurgery NCT00247403 | University of Iowa | Phase 1 |
| Completed | Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases NCT00328575 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 |
| Completed | Clinical Study of Previously Untreated Patients With Malignant Melanoma NCT00232726 | Clavis Pharma | Phase 2 |
| Completed | An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Ca NCT00207116 | Eli Lilly and Company | Phase 1 |
| Terminated | A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Di NCT00099177 | Hoffmann-La Roche | Phase 3 |
| Completed | Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases NCT00434317 | Novartis | Phase 4 |
| Completed | Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer NCT00130689 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Vaccination of Patients With Stage IV Melanoma With Dendritic Cells NCT00125749 | Baylor Research Institute | Phase 1 / Phase 2 |
| Completed | Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC) NCT00125034 | Merck KGaA, Darmstadt, Germany | Phase 2 |
| Completed | Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of NCT00165568 | Dana-Farber Cancer Institute | Phase 2 |
| Terminated | A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful B NCT00099203 | Hoffmann-La Roche | Phase 3 |
| Completed | Metastatic Gastric Cancer FFCD 03-07 NCT00374036 | University Hospital, Toulouse | Phase 3 |
| Completed | Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tum NCT00731861 | Indiana University School of Medicine | Phase 1 |
| Terminated | Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer NCT00120172 | Geriatric Oncology Consortium | Phase 2 |
| Unknown | Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases NCT00268684 | Tel-Aviv Sourasky Medical Center | Phase 3 |
| Completed | Characterization of Brain Metastases NCT00184275 | Norwegian University of Science and Technology | — |
| Terminated | A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer NCT00102895 | Pfizer | Phase 2 |
| Unknown | Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma NCT00116363 | Introgen Therapeutics | Phase 2 |
| Completed | Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer NCT00116506 | Dana-Farber Cancer Institute | Phase 2 |
| Withdrawn | Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response. NCT00184288 | Norwegian University of Science and Technology | — |
| Completed | Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis NCT00172003 | Novartis Pharmaceuticals | Phase 4 |
| Completed | MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors NCT00207103 | Bristol-Myers Squibb | Phase 1 |
| Completed | Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer NCT00444678 | NYU Langone Health | Phase 2 |
| Completed | Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases NCT00083785 | Light Sciences LLC | Phase 2 |
| Terminated | Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer NCT00083993 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Terminated | Safety Study of High Dose Temozolomide to Treat Relapsed/Refractory Central Nervous System (CNS) Malignancy NCT00629187 | Tufts Medical Center | Phase 1 |
| Completed | Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) NCT00076856 | Merck Sharp & Dohme LLC | Phase 2 |
| Unknown | Circulating Tumor Cells in Patients With Metastatic Colorectal Cancer NCT00133913 | Immunicon | — |
| Completed | Docetaxel and Capecitabine in Advanced Gastric Cancer NCT00142038 | Charite University, Berlin, Germany | Phase 2 |
| Completed | A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate Can NCT00459654 | Bayer | Phase 2 |
| Completed | Sex-Specific Machine Learning Models to Predict Distant Metastasis in Liver Cancer NCT07386639 | Tongji University | — |
| Completed | Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors NCT00075166 | National Institute of Neurological Disorders and Stroke (NINDS) | Phase 4 |
| Completed | Dexamethasone for Palliation - Brain Metastases NCT00188864 | University Health Network, Toronto | Phase 2 |
| Completed | Tarceva and Capecitabine for Pancreatic Cancer NCT00125021 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metas NCT00068068 | Light Sciences LLC | Phase 2 |
| Completed | Analyses of Human Samples Collected in Clinical Trials NCT00339664 | National Cancer Institute (NCI) | — |
| Completed | PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial) NCT00221702 | University Hospital, Bordeaux | Phase 3 |
| Completed | Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Ther NCT00067314 | Pfizer | Phase 2 |
| Completed | ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) NCT00101920 | Amgen | Phase 2 |
| Completed | Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer NCT00072865 | Eli Lilly and Company | Phase 2 |
| Completed | A Research Study for Patients With Metastatic Renal Cell Carcinoma NCT00106613 | Celgene | Phase 2 |
| Completed | Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer NCT00123851 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Me NCT00055562 | Celgene Corporation | Phase 2 / Phase 3 |
| Completed | A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases NCT00124761 | Royal Adelaide Hospital | Phase 3 |
| Completed | A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis NCT00149201 | Japan Clinical Oncology Group | Phase 3 |
| Completed | Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma NCT00057616 | Celgene | Phase 3 |
| Completed | Irinotecan Versus Only Best Supportive Care for Gastric Cancer NCT00144378 | Charite University, Berlin, Germany | Phase 3 |
| Completed | Study of NS-9 in Patients With Liver Metastases NCT00094003 | NS Pharma, Inc. | Phase 1 |
| Terminated | Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions NCT00130494 | Spanish Breast Cancer Research Group | Phase 3 |
| Completed | Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With C NCT00171587 | Novartis | Phase 1 / Phase 2 |
| Completed | Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions NCT00171964 | Novartis Pharmaceuticals | Phase 4 |
| Terminated | For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy NCT00037180 | Pfizer | Phase 2 |
| Completed | Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases NCT00119899 | Radboud University Medical Center | Phase 3 |
| Unknown | A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer NCT00122291 | Alberta Health services | Phase 2 |
| Completed | ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cance NCT00034346 | Amgen | Phase 2 |
| Completed | PG2 Phase I/II Clinical Study Intravenously Administered in Patients With Advanced Malignancy NCT01696565 | PhytoHealth Corporation | Phase 1 / Phase 2 |
| Completed | Study of Noni in Cancer Patients NCT00033878 | National Center for Complementary and Integrative Health (NCCIH) | Phase 1 |
| Completed | ADI-PEG in Patients With Metastatic Melanoma NCT00029900 | FDA Office of Orphan Products Development | Phase 1 |
| Completed | Dose Escalation Study of Radium-223 Dichloride in Patients With Advanced Skeletal Metastases NCT01798108 | Bayer | Phase 1 |
| Completed | Helical Tomotherapy as a Radiotherapy Technique for Treating Pelvic and Abdominal Metastases NCT00129051 | Alberta Health services | Phase 1 |
| Withdrawn | Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host NCT00149032 | Hadassah Medical Organization | Phase 2 |
| Terminated | Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas NCT00023166 | Enzon Pharmaceuticals, Inc. | Phase 1 |
| Terminated | Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia NCT00127387 | The University of Texas Health Science Center at San Antonio | Phase 2 / Phase 3 |
| Unknown | Molecular Markers in Treatment in Endometrial Cancer NCT00598845 | University of Bergen | — |
| Completed | Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients NCT00128310 | Spanish Breast Cancer Research Group | Phase 3 |
| Completed | Pamidronate Administration in Breast Cancer Patients With Bone Metastases NCT00128297 | Spanish Breast Cancer Research Group | Phase 4 |
| Completed | Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria NCT00004988 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line NCT00289445 | University Hospital Tuebingen | Phase 1 / Phase 2 |
| Completed | Oxaliplatin in Cancer Patients With Impaired Kidney Function NCT00001835 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma NCT00001832 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Stem Cell Transplantation for Metastatic Solid Tumors NCT00001880 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Ca NCT00190489 | Japan Clinical Oncology Group | Phase 3 |
| Completed | Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum NCT00001705 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma NCT00401323 | Sanofi | Phase 2 / Phase 3 |
| Completed | Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From NCT00001685 | National Cancer Institute (NCI) | Phase 2 |
| Completed | A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients With Refractory NCT00001683 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Pri NCT00001587 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic NCT00001576 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Rena NCT00001570 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Chemotherapy and Progenitor Cell Transplantation to Treat Inflammatory Breast Cancer NCT00001507 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases NCT00138788 | St George Hospital, Australia | Phase 3 |
| Completed | Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gen NCT00001493 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of V NCT00001440 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteos NCT00001436 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Direct Injection of Alcohol for the Treatment of Spinal Tumors NCT00001417 | National Institute of Neurological Disorders and Stroke (NINDS) | — |
| Completed | A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 NCT00001302 | National Cancer Institute (NCI) | Phase 1 |